Copyright
©The Author(s) 2022.
World J Gastroenterol. Nov 28, 2022; 28(44): 6271-6281
Published online Nov 28, 2022. doi: 10.3748/wjg.v28.i44.6271
Published online Nov 28, 2022. doi: 10.3748/wjg.v28.i44.6271
Figure 1 The receiver operating characteristic analysis of the sum of tumor size and number, the classification of the sum of tumor size and number, tumor burden score and total tumor volume in intermediate-stage hepatocellular carcinoma patients.
A: 3-year overall survival (OS); B: 5-year OS. N + S: The sum of tumor size and number; TBS: Tumor burden score; TTV: Total tumor volume; AUC: Area under receiver operating characteristic curve.
Figure 2 Comparison of overall survival and recurrence-free survival in multinodular hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer stage A, B1 and B2.
A: overall survival; B: recurrence-free survival. BCLC: Barcelona Clinic Liver Cancer; MNHCC: Multinodular hepatocellular carcinoma.
Figure 3 Comparison of recurrence-to-death survival in Barcelona Clinic Liver Cancer stage A, B1 and B2 multinodular hepatocellular carcinoma patients with recurrence.
BCLC: Barcelona Clinic Liver Cancer.
- Citation: Hu XS, Yang HY, Leng C, Zhang ZW. Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number. World J Gastroenterol 2022; 28(44): 6271-6281
- URL: https://www.wjgnet.com/1007-9327/full/v28/i44/6271.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i44.6271